Effects of SMC1A on Immune Microenvironment and Cancer Stem Cells in Colon Adenocarcinoma

Overview

Journal Cancer Med

Specialty Oncology

Date 2023 Apr 25

PMID 37096492

Authors

Jin Li

Qian Zhou

Li Liu

Jingdong He

Affiliations

Soon will be listed here.

Abstract

Background: Our previous study suggested that SMC1 has significant functions in colorectal cancer (CRC). However, few reports have shown the effects of structural maintenance of chromosomes 1 (SMC1A) on the immune microenvironment and tumor stem cells.

Methods: The Cancer Genome Atlas (TCGA) database, CPTAC database, Human Protein Atlas (HPA) database, the Cancer Cell Line Encyclopedia (CCLE) and Tumor Immune Single-cell Hub were used. Flow cytometry and immunohistochemical analysis were checked for immune infiltration on MC38 mice model. Human CRC tissues were tested with RT-qPCR.

Results: The mRNA and protein levels of SMC1A were increased in colon adenocarcinoma (COAD) samples. SMC1A was associated with DNA activity. Interestingly, SMC1A was highly expressed in many types of immune cells at single-cell levels. Moreover, the high expression of SMC1A was positively correlated with immune infiltration, and immunohistochemical analysis showed that SMC1A was positively associated with CD45 expression in MC38 mice model. Also, the percentage of IL4 CD4 T cells (Th2) and FoxP3 CD4 T cells (Tregs) was significantly higher in the SMC1A overexpression group than in control by flow cytometry assay in vivo. SMC1A expression could affect the proliferation of T cells in the mice model. The mutation and somatic cell copy number variation (SCNV) of SMC1A were also associated with immune cell infiltration. In addition to SMC1A in the "hot" T-cell inflammatory microenvironment of colon cancer, SMC1A also positively correlates with the immune checkpoint genes CD274, CTLA4, and PDCD1 in colon adenocarcinoma (COAD) samples. Furthermore, we also found that SMC1A plays a positive correlation with the induction of cancer stem cells (CSCs). Our results also showed that miR-23b-3p binds SMC1A.

Conclusion: SMC1A may be a bidirectional target switch that simultaneously regulates the immune microenvironment and tumor stem cells. Moreover, SMC1A may be a biomarker for the prediction of immune checkpoint inhibitor (ICI) therapy.

Citing Articles

Increased interferon I signaling, DNA damage response and evidence of T-cell exhaustion in a patient with combined interferonopathy (Aicardi-Goutières Syndrome, AGS) and cohesinopathy (Cornelia de Lange Syndrome, CdLS).

Boiu S, Paschalidis N, Sentis G, Manolakou T, Nezos A, Gialitakis M Pediatr Rheumatol Online J. 2025; 23(1):11.

PMID: 39871364 PMC: 11770959. DOI: 10.1186/s12969-024-01050-7.

Association of Structural Maintenance of Chromosome-1A Phosphorylation with Progression of Breast Cancer.

Yadav S, Kowolik C, Schmolze D, Yuan Y, Lin M, Riggs A Cells. 2025; 14(2).

PMID: 39851557 PMC: 11764376. DOI: 10.3390/cells14020128.

The Role of Tumor Stem Cells in Colorectal Cancer Drug Resistance.

Zhong C, Wang G, Guo M, Zhu N, Chen X, Yan Y Cancer Control. 2024; 31:10732748241274196.

PMID: 39215442 PMC: 11367616. DOI: 10.1177/10732748241274196.

Silencing LY6D Expression Inhibits Colon Cancer in Xenograft Mice and Regulates Colon Cancer Stem Cells' Proliferation, Stemness, Invasion, and Apoptosis via the MAPK Pathway.

Duan J, Wang Y, Chen Y, Wang Y, Li Q, Liu J Molecules. 2023; 28(23).

PMID: 38067506 PMC: 10708431. DOI: 10.3390/molecules28237776.

Effects of SMC1A on immune microenvironment and cancer stem cells in colon adenocarcinoma.

Li J, Zhou Q, Liu L, He J Cancer Med. 2023; 12(11):12881-12895.

PMID: 37096492 PMC: 10278469. DOI: 10.1002/cam4.5891.

References

Musio A . The multiple facets of the SMC1A gene. Gene. 2020; 743:144612. PMC: 8011328. DOI: 10.1016/j.gene.2020.144612. View

Li J, Feng W, Chen L, He J . Downregulation of SMC1A inhibits growth and increases apoptosis and chemosensitivity of colorectal cancer cells. J Int Med Res. 2015; 44(1):67-74. PMC: 5536575. DOI: 10.1177/0300060515600188. View

Rawlings J . Roles of SMC Complexes During T Lymphocyte Development and Function. Adv Protein Chem Struct Biol. 2017; 106:17-42. DOI: 10.1016/bs.apcsb.2016.08.001. View

Zhang Y, Yi F, Wang L, Wang Z, Zhang N, Wang Z . Phosphorylation of SMC1A promotes hepatocellular carcinoma cell proliferation and migration. Int J Biol Sci. 2018; 14(9):1081-1089. PMC: 6036730. DOI: 10.7150/ijbs.24692. View

Hanzelmann S, Castelo R, Guinney J . GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013; 14:7. PMC: 3618321. DOI: 10.1186/1471-2105-14-7. View

Takeuchi Y, Nishikawa H . Roles of regulatory T cells in cancer immunity. Int Immunol. 2016; 28(8):401-9. PMC: 4986235. DOI: 10.1093/intimm/dxw025. View

Xu T, Yu W, Li Q, Li X, Shi Y, Cao B . MicroRNA-524 inhibits the progress of glioma via the direct targeting of NCF2. Am J Transl Res. 2019; 11(3):1605-1615. PMC: 6456563. View

Uhlen M, Fagerberg L, Hallstrom B, Lindskog C, Oksvold P, Mardinoglu A . Proteomics. Tissue-based map of the human proteome. Science. 2015; 347(6220):1260419. DOI: 10.1126/science.1260419. View

Musio A, Montagna C, Mariani T, Tilenni M, Focarelli M, Brait L . SMC1 involvement in fragile site expression. Hum Mol Genet. 2005; 14(4):525-33. DOI: 10.1093/hmg/ddi049. View

10.

Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin A, Kim S . The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012; 483(7391):603-7. PMC: 3320027. DOI: 10.1038/nature11003. View

11.

Li K, Ying M, Feng D, Chen Y, Wang J, Wang Y . SMC1 promotes epithelial-mesenchymal transition in triple-negative breast cancer through upregulating Brachyury. Oncol Rep. 2016; 35(4):2405-12. DOI: 10.3892/or.2016.4564. View

12.

Manic G, Sistigu A, Corradi F, Musella M, De Maria R, Vitale I . Replication stress response in cancer stem cells as a target for chemotherapy. Semin Cancer Biol. 2018; 53:31-41. DOI: 10.1016/j.semcancer.2018.08.003. View

13.

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

14.

. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019; 4(12):913-933. PMC: 7026697. DOI: 10.1016/S2468-1253(19)30345-0. View

15.

Mannini L, Menga S, Tonelli A, Zanotti S, Bassi M, Magnani C . SMC1A codon 496 mutations affect the cellular response to genotoxic treatments. Am J Med Genet A. 2011; 158A(1):224-8. DOI: 10.1002/ajmg.a.34384. View

16.

Benson A, Venook A, Al-Hawary M, Cederquist L, Chen Y, Ciombor K . NCCN Guidelines Insights: Colon Cancer, Version 2.2018. J Natl Compr Canc Netw. 2018; 16(4):359-369. PMC: 10184502. DOI: 10.6004/jnccn.2018.0021. View

17.

Barber T, McManus K, Yuen K, Reis M, Parmigiani G, Shen D . Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. Proc Natl Acad Sci U S A. 2008; 105(9):3443-8. PMC: 2265152. DOI: 10.1073/pnas.0712384105. View

18.

Le D, Uram J, Wang H, Bartlett B, Kemberling H, Eyring A . PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med. 2015; 372(26):2509-20. PMC: 4481136. DOI: 10.1056/NEJMoa1500596. View

19.

Li J, He J, Wang Y, Shu Y, Zhou J . SMC1 promotes proliferation and inhibits apoptosis through the NF‑κB signaling pathway in colorectal cancer. Oncol Rep. 2019; 42(4):1329-1342. PMC: 6718103. DOI: 10.3892/or.2019.7273. View

20.

Andres J, Grinan-Lison C, Jimenez G, Marchal J . Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment. J Hematol Oncol. 2020; 13(1):136. PMC: 7559894. DOI: 10.1186/s13045-020-00966-3. View